Kohei Shitara

Company: National Cancer Center Hospital East

Job title: Director of the GI Oncology department

Seminars:

Zolbetuximab: Clinical Development of Claudin 18.2 Monoclonal Antibodies 9:00 am

Exploring Zolbetuximab, a monoclonal antibody targeting claudin 18.2, and its application in treating metastatic gastric cancer Reviewing a detailed presentation on clinical trial outcomes, including efficacy, safety, and the impact on progression-free survival and overall survival rates Integrating Zolbetuximab into standard treatment regimens and its potential for combination with other therapeutic modalitiesRead more

day: Conference Day 1